Onego Bio Submits Formal GRAS Notification to FDA for Bioalbumen®

Contributed by: Business Wire

Logo

Tags

Environment

Technology

FDA

Environmental Health

Biotechnology

Food/Beverage

Health

Supply Chain Management

Retail

Food Tech

More Like This

Onego Bio Receives FDA “No Questions” Letter on GRAS Status of Bioalbumen®

Onego Bio and Sigma Foods Enter Collaboration to Strengthen Egg Protein Innovation and Supply Resilience

Onego Bio Launches “The Power of Trichoderma reesei” Series to Showcase Innovation, Scale, and Real-World Applications

Dr. Antti Vasara

Onego Bio Strengthens Board with Appointment of Dr. Antti Vasara

21st.BIO obtains self-affirmed GRAS status for its precision fermented beta-lactoglobulin: 21st.BIO customers can now enter the U.S. market with their own production using 21st.BIO technology

21st.BIO launches precision fermentation program for bovine alpha-lactalbumin

GlobeNewswire associated0

Sweden’s Millow Commissions World‑First Oat‑and‑Mycelium Factory to Craft Beef‑Like, Clean‑Label Protein

21ST.BIO OPENS A MORE SUSTAINABLE AVENUE FOR INDUSTRIAL SCALE DAIRY PROTEIN PRODUCTION